Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 16,691 | 9,242 | 4,616 | 51,907 | 6,421 |
| Cost of Goods | 18,028 | 7,820 | 5,827 | 4,600 | 5,735 |
| Gross Profit | -1,337 | 1,422 | -1,211 | 47,307 | 686 |
| Operating Expenses | 36,152 | 31,598 | 32,648 | 33,495 | 40,079 |
| Operating Income | -37,465 | -29,353 | -33,031 | 14,412 | -38,656 |
| Interest Expense | 10,443 | 4,250 | 2,821 | 0 | 2,119 |
| Other Income | 3,277 | 1 | 0 | 2,190 | -593 |
| Pre-tax Income | -44,631 | -33,602 | -35,852 | 16,602 | -41,368 |
| Net Income Continuous | -44,631 | -33,602 | -35,852 | 16,602 | -41,368 |
| Minority Interests | -6,035 | -3,305 | -3,589 | -3,480 | -3,970 |
| Net Income | $-38,596 | $-30,297 | $-32,263 | $20,082 | $-37,398 |
| EPS Basic Total Ops | -0.91 | -0.71 | -0.76 | 0.47 | -0.88 |
| EPS Basic Continuous Ops | -1.05 | -0.79 | -0.84 | 0.39 | -0.97 |
| EPS Diluted Total Ops | -0.91 | -0.71 | -0.76 | 0.47 | -0.88 |
| EPS Diluted Continuous Ops | -1.05 | -0.79 | -0.84 | 0.39 | -0.97 |
| EBITDA(a) | $-34,418 | $-26,779 | $-30,886 | $16,465 | $-36,722 |